LIMERICK, Pa., Jan 03, 2011 (BUSINESS WIRE) --
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical
technology products, announces that on Friday, December 31, 2010 it
completed the previously announced sale of its subsidiary Telair
International Incorporated's Actuation business to TransDigm Group
Incorporated (NYSE: TDG). The sale proceeds are approximately $94
million.
Actuation will be reflected as a discontinued operation in Teleflex's
future consolidated financial statements.
About Teleflex Incorporated
Teleflex is a global provider of medical technology products that enable
healthcare providers to improve patient outcomes, reduce infections and
support patient and provider safety. Teleflex, which employs
approximately 12,800 people worldwide, also has niche businesses that
serve segments of the aerospace and commercial markets with specialty
engineered products. Additional information about Teleflex can be
obtained from the company's website at www.teleflex.com.
SOURCE: Teleflex Incorporated
Teleflex Incorporated
Jake Elguicze
Vice President
Investor Relations
610-948-2836